Gala-SR
Gala-SR (Gala-SR1078) is an RORα agonist. Gala-SR ameliorates rhythm disorders by enhancing the amplitude of the circadian rhythm. Gala-SR can be used for the study of periodontitis.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 3092129-97-7
- 分子式: C24H22F9NO8
- 分子量:623.42
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
生物活性
|
RORα |
Gala-SR (1-100 μM, 24-72 h) significantly improved Human U2OS cell compatibility through galactose modification[1].
Gala-SR (5 μM, 24 h) significantly upregulates the mRNA expression of G6Pase and FGF21, direct target genes of RORα/γ, in HepG2 cells[1].
Gala-SR (5 μM) selectively enhances RORα transcriptional activation activity in HEK293T cells[1].
Gala-SR (5 μM, 24 h) shows significantly reduced activation effects on the G6Pase and FGF21 genes after RORα is knocked down[1].
Gala-SR (5 μM) targets and activates RORα primarily through its hydrolyzable galactose modification[1].
Gala-SR (2-5 μM) significantly enhances the bioluminescence levels and rhythmic amplitude of the BMAL1 and Per2 reporter genes in U2OS cells, and enhances the expression of the BMAL1 protein[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HepG2 cells
-
Concentration:5 μM
-
Incubation Time:24 h
-
Result:Upregulated the mRNA expression of G6Pase and FGF21, direct target genes of RORα/γ, in HepG2 cells.
Gala-SR (10 mg/kg, lights on, once) enhances liver luciferase signaling in PER2::LUC knock-in mice, indicating enhanced BMAL1 expression[1].
Gala-SR (10 mg/kg, i.p., once daily for 3 weeks) restores the amplitude of periodontal tissue rhythm in periodontal mice with periodontitis, inhibits the NF-κB inflammatory pathway, and alleviates periodontitis-related bone loss[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6J mice were first acclimatized to a 12-hour light/12-hour dark (L:D) condition for 2 weeks, and then switched to continuous darkness (D:D) to induce circadian rhythm disorder[1].
-
Dosage:10 mg/kg
-
Administration:1 hour before the end of the light exposure, i.p., once daily for 2 weeks
-
Result:Significantly enhanced the amplitude of the activity rhythm and the total activity level in mice.
-
Animal Model:PER2::LUC gene knock-in mice[1].
-
Dosage:10 mg/kg
-
Administration:I.p., once, light start time
-
Result:Enhanced liver luciferase signaling indicates increased BMAL1 expression.
-
Animal Model:Male C57BL/6 mice, 2 months old, were housed under disrupted conditions for 4 weeks, and a ligature was placed around the cervix of the maxillary second molar to establish the murine periodontitis model[1].
-
Dosage:10 mg/kg
-
Administration:I.p., once daily for 3 weeks
-
Result:Significantly reduced alveolar bone resorption (increased bone volume/total volume, reduced bone resorption height).
Reduced inflammatory cell infiltration and osteoclast activity.
Downregulated pro-inflammatory factors (TNF-α, IL-6) and upregulates anti-inflammatory factors (IL-10).
化学情報
-
CAS 番号 3092129-97-7
-
分子量 623.42
-
分子式 C24H22F9NO8
-
SMILES
OC[C@H]1O[C@@H](OCOC(C(F)(F)F)(C(F)(F)F)C2=CC=C(NC(C3=CC=C(C(F)(F)F)C=C3)=O)C=C2)[C@H](O)[C@@H](O)[C@H]1O
-
別名
Gala-SR1078
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Gala-SR 関連分類
HY-179514 関連分類
Powered by Bioz